Date updated:08-06-2008
The traders looked at some trade ideas and options action in the biotech space.

-
BMY
Bristol Myers Sqi - $22.18
- -0.76%
- $22.25
News of the Bristol-Meyers (BMY) offer to buy out ImClone (IMCL) deal triggered a flurry of option activity in Amgen (AMGN), Onyx Pharmaceuticals (ONXX), and Amylin (AMLN) said option strategist Frederic Ruffy.

-
IMCL
Imcl - $0.00
- N/A
- $N/A
News of the Bristol-Meyers (BMY) offer to buy out ImClone (IMCL) deal triggered a flurry of option activity in Amgen (AMGN), Onyx Pharmaceuticals (ONXX), and Amylin (AMLN) said option strategist Frederic Ruffy.

-
AMGN
Amgen Inc. - $58.20
- -0.24%
- $57.83
News of the Bristol-Meyers (BMY) offer to buy out ImClone (IMCL) deal triggered a flurry of option activity in Amgen (AMGN), Onyx Pharmaceuticals (ONXX), and Amylin (AMLN) said option strategist Frederic Ruffy.

-
ONXX
Onyx Pharmaceutic - $35.47
- -2.82%
- $36.06
News of the Bristol-Meyers (BMY) offer to buy out ImClone (IMCL) deal triggered a flurry of option activity in Amgen (AMGN), Onyx Pharmaceuticals (ONXX), and Amylin (AMLN) said option strategist Frederic Ruffy.

-
AMLN
Amylin Pharmaceut - $11.31
- -6.91%
- $12.02
News of the Bristol-Meyers (BMY) offer to buy out ImClone (IMCL) deal triggered a flurry of option activity in Amgen (AMGN), Onyx Pharmaceuticals (ONXX), and Amylin (AMLN) said option strategist Frederic Ruffy.

-
BIIB
Biogen Idec Inc - $46.81
- +0.73%
- $46.13
I’m sniffing around Biogen (BIIB), says Karen Finerman. I think it was too beaten down.

-
CELG
Celgene Corporati - $51.50
- +2.04%
- $50.05
I still think the best play here IS Celgene (CELG) says Guy Adami. They could be a takeover target.
- Top Professional Portfolios
- 1. Charlie Munger
- 2. Bernard L. Madoff Inve...
- 3. Renaissance Technologies
- 4. Fidelity Select Consum...
- 5. Templeton World A (TEMWX)
- show all
- Top Do-It-Yourself Portfolios
- » Joy
- » tsamanuli Portfolio 1
- » brueckenc Portfolio 1
- » HMH1
- » Fundsonly Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » 10 Short Squeezes
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- show all
Stocks were mixed yesterday after retailers reported their numbers for the Christmas season. Wal-Mart (WMT), the nation's largest retailer, said December sales at stores...
Activist investing is never an easy task, but by following the latest activist filings, you can piggyback off of some of the smartest money managers and hedge funds ever. ...
Jim Cramer is optimistic on the stock market for 2009. According to his analysis, the Dow Jones Industrial Average could produce a gain of 13.1% this year based on his pred...
Investors were spooked on Wednesday as bleak broad-based corporate outlooks and dismal employment data dominated headlines. Stocks experienced their largest drop in more t...
A. There IS an advantage to ariticulate
one's gameplan, whether a trader or an
investor.
As an investment (at least one year and
a day), NOV and RIG represent money in
the bank.
NOV is deep in the money (on hand) with
respectable backlog of orders and RIG is
best of breed deep sea driller currently
operating where the proven oil reserve
is for the future.
A. small trading before thrusday
These stocks were upgraded by TheStreet.com Ratings on Dec. 29, 2008. more
These stocks were downgraded by TheStreet.com Ratings on Dec. 29, 2008. more
Here are some of the biggest stocks that made the 52-week high list on Jan. 8, 2009. more






Comments not available